volume 15 issue 2 pages 163-205

Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation

Olga Golubnitschaja 1
Andrea Kapinova 2
Nafiseh Sargheini 3
Bianka Bojkova 4
Marko Kapalla 5, 6
Luisa Heinrich 7
Eleni Gkika 8
Peter Kubatka 9
Publication typeJournal Article
Publication date2024-04-18
scimago Q1
wos Q1
SJR1.421
CiteScore11.6
Impact factor5.9
ISSN18785077, 18785085
Drug Discovery
Health Policy
Biochemistry (medical)
Abstract

Despite their subordination in humans, to a great extent, mitochondria maintain their independent status but tightly cooperate with the “host” on protecting the joint life quality and minimizing health risks. Under oxidative stress conditions, healthy mitochondria promptly increase mitophagy level to remove damaged “fellows” rejuvenating the mitochondrial population and sending fragments of mtDNA as SOS signals to all systems in the human body. As long as metabolic pathways are under systemic control and well-concerted together, adaptive mechanisms become triggered increasing systemic protection, activating antioxidant defense and repair machinery. Contextually, all attributes of mitochondrial patho-/physiology are instrumental for predictive medical approach and cost-effective treatments tailored to individualized patient profiles in primary (to protect vulnerable individuals again the health-to-disease transition) and secondary (to protect affected individuals again disease progression) care. Nutraceuticals are naturally occurring bioactive compounds demonstrating health-promoting, illness-preventing, and other health-related benefits. Keeping in mind health-promoting properties of nutraceuticals along with their great therapeutic potential and safety profile, there is a permanently growing demand on the application of mitochondria-relevant nutraceuticals. Application of nutraceuticals is beneficial only if meeting needs at individual level. Therefore, health risk assessment and creation of individualized patient profiles are of pivotal importance followed by adapted nutraceutical sets meeting individual needs. Based on the scientific evidence available for mitochondria-relevant nutraceuticals, this article presents examples of frequent medical conditions, which require protective measures targeted on mitochondria as a holistic approach following advanced concepts of predictive, preventive, and personalized medicine (PPPM/3PM) in primary and secondary care.

Found 
Found 

Top-30

Journals

2
4
6
8
10
12
14
16
EPMA Journal
15 publications, 51.72%
Journal of Advanced Research
5 publications, 17.24%
Biochemical Pharmacology
2 publications, 6.9%
Biomedicine and Pharmacotherapy
1 publication, 3.45%
Journal of Medicinal Chemistry
1 publication, 3.45%
Molecules
1 publication, 3.45%
Molecular Biology Reports
1 publication, 3.45%
Protein and Cell
1 publication, 3.45%
Progress in Biophysics and Molecular Biology
1 publication, 3.45%
2
4
6
8
10
12
14
16

Publishers

2
4
6
8
10
12
14
16
Springer Nature
16 publications, 55.17%
Elsevier
9 publications, 31.03%
American Chemical Society (ACS)
1 publication, 3.45%
MDPI
1 publication, 3.45%
Oxford University Press
1 publication, 3.45%
IGI Global
1 publication, 3.45%
2
4
6
8
10
12
14
16
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
29
Share
Cite this
GOST |
Cite this
GOST Copy
Golubnitschaja O. et al. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation // EPMA Journal. 2024. Vol. 15. No. 2. pp. 163-205.
GOST all authors (up to 50) Copy
Golubnitschaja O., Kapinova A., Sargheini N., Bojkova B., Kapalla M., Heinrich L., Gkika E., Kubatka P. Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation // EPMA Journal. 2024. Vol. 15. No. 2. pp. 163-205.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s13167-024-00358-4
UR - https://link.springer.com/10.1007/s13167-024-00358-4
TI - Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation
T2 - EPMA Journal
AU - Golubnitschaja, Olga
AU - Kapinova, Andrea
AU - Sargheini, Nafiseh
AU - Bojkova, Bianka
AU - Kapalla, Marko
AU - Heinrich, Luisa
AU - Gkika, Eleni
AU - Kubatka, Peter
PY - 2024
DA - 2024/04/18
PB - Springer Nature
SP - 163-205
IS - 2
VL - 15
PMID - 38841620
SN - 1878-5077
SN - 1878-5085
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Golubnitschaja,
author = {Olga Golubnitschaja and Andrea Kapinova and Nafiseh Sargheini and Bianka Bojkova and Marko Kapalla and Luisa Heinrich and Eleni Gkika and Peter Kubatka},
title = {Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation},
journal = {EPMA Journal},
year = {2024},
volume = {15},
publisher = {Springer Nature},
month = {apr},
url = {https://link.springer.com/10.1007/s13167-024-00358-4},
number = {2},
pages = {163--205},
doi = {10.1007/s13167-024-00358-4}
}
MLA
Cite this
MLA Copy
Golubnitschaja, Olga, et al. “Mini-encyclopedia of mitochondria-relevant nutraceuticals protecting health in primary and secondary care—clinically relevant 3PM innovation.” EPMA Journal, vol. 15, no. 2, Apr. 2024, pp. 163-205. https://link.springer.com/10.1007/s13167-024-00358-4.